Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy

B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy (BCMA CAR-T) is an effective treatment of relapsed refractory multiple myeloma (MM). However, the pattern of infectious complications is not well elucidated. We performed a single-center retrospective analysis of infection o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kambhampati, Swetha, Sheng, Ying, Huang, Chiung-Yu, Bylsma, Sophia, Lo, Mimi, Kennedy, Vanessa, Natsuhara, Kelsey, Martin, Thomas, Wolf, Jeffrey, Shah, Nina, Wong, Sandy W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006279/
https://www.ncbi.nlm.nih.gov/pubmed/34543400
http://dx.doi.org/10.1182/bloodadvances.2020004079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006279/
https://www.ncbi.nlm.nih.gov/pubmed/34543400
http://dx.doi.org/10.1182/bloodadvances.2020004079

Ejemplares similares